A recent study demonstrated, using an acetylation-defective p53-4KR mouse model, that p53’s ability to suppress mTOR function is linked to distinctive tumor-suppressive activities independent of cell cycle arrest, senescence, and apoptosis (Kon et al., 2021). This evidence concerns the gene TP53 and neoplasm.